Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2020
View Archived Issues
First COVID-19 patients dosed in phase II study of peginterferon lambda-1a
Read More
FDA clears IND application for ZN-d5 for hematologic malignancies
Read More
Pancreatic cancer uses autophagy to hide from immune system
Read More
Mesoblast initiates phase II/III study of remestemcel-L in patients with COVID-19 ARDS
Read More
SIAIS-117, novel ALK degrader as potential therapy for ALK-positive cancer types
Read More
Discovery of a novel highly potent and orally active EED inhibitor
Read More
Novartis presents preclinical data for TNO-155
Read More
Terns patents new THR-beta agonists
Read More
Thwarting the hijacker: in vitro study gives "blueprint", drug leads for SARS-CoV-2
Read More
Tumor burden reduction seen with Pexa-Vec vaccine in phase I renal cell carcinoma trial
Read More
Janssen BioPharma presents new antivirals
Read More
Sareum Holdings identifies TYK2 inhibitors
Read More
Morphic Therapeutic synthesizes integrin alphavbeta6 antagonists
Read More
Medshine Discovery divulges new GLS1 inhibitors
Read More
Restoring synaptic transmission for rare neurodevelopmental disease
Read More
Neutralizing RSV
Read More
Loss-of-function variant in CDC25B causes a syndrome including cardiomyopathy and endocrinopathies
Read More
Serum amyloid A may be useful as a marker of COVID-19 severity and prognosis
Read More
Preclinical and preliminary phase I results presented for menin/MLL interaction inhibitor SNDX-5613
Read More
IPN-60090: a GLS1 inhibitor for the oral treatment of KEAP1/NFE2L2-mutant NSCLC and ASNS-low HGSOC
Read More
Phase II trial of nomacopan in bullous pemphigoid meets primary and key secondary efficacy endpoints
Read More
Newron discontinues development of sarizotan in Rett syndrome following STARS data
Read More
RECCE-327 shows significant antibacterial activity against N. gonorrhoeae bacteria in mice
Read More
FDA approves Darzalex Faspro for multiple myeloma
Read More
Phase IIb study of STA-363 for disc-related low back pain cleared to begin in Spain
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe